Skip to main content
. 2013 Dec;33(24):4900–4908. doi: 10.1128/MCB.01041-13

Table 1.

Oligonucleotides used

Purpose and DNA oligonucleotide Sequence
Probes
    Ser AGA ACL CCAATGGATTTCTAGTCCATCGC
    Ser AGA body GCAGGATTCGAACCTGCGCGG
    Ser CGA ACL CCCATTGGATTTCGAGTCCAACGCCT
    Ser CGA body AGCAGGATTCGACCTGCGCGGGG
    Ser UGA ACL CCCATTGGATTTCAAGTCCAACGC
    Ser UGA body GCAGGATTCGAACCTGCGCGGG
    Leu CAA ACL CCATTCAGATTTTGAGACTGATGCG
    Leu CAA body CCTCTGAGGCTTGAACTCAG
    Leu UAA-1 ACL GATTATAAAATTTTAAGTTTTATGC
    Leu UAA-1 body GTTAAGAAGAGGAGTTGAACC
    Leu UAA-2 ACL TTATAAAGTTTTAAGTCTTATG
    Leu UAA-2 body GTTAATGTGAGGAGTTGTACC
    Sec ACL GCTACAGGTTTGAAGCCTGCACC
    Sec body CAAAGGTGGAATTGAACCACTC
    Sec-3 body CACAAAGGGACTCAAACC
    mt Ser UGA ACL CAAAGCTGGTTTCAAGCCAACCCC
    mt Ser UGA body AAGGAAGGAATCGAACCCCCC
    mt Trp UCA ACL CTGAGGGCTTTGAAGGCTCTTGG
    mt Trp UCA body GAAATTAAGTATTGCAACTTAC
    mt Phe GAA ACL GTCTAAACATTTTCAGTGTATTGC
    mt Phe GAA body GTGTTTATGGGGTGATGTGATGTGAGCC
    mt Leu UUA ACL GACTGTAAAGTTTTAAGTTTTATGC
    mt Leu UUA body GTTAAGAAGAGGAATTGAACCTC
    mt Tyr GUA ACL TCTTTAGATTTACAGTCCAATGC
    mt Tyr GUA body GGTAAAAAGAGGCCTAACCCCTG
    mt Cys GCA ACL TCTTCGAATTTGCAATTCAATATG
    mt Cys GCA body AGCCCCGGCAGGTTTGAAGCT
Antisense to eliminate tRNAs with RNase H
    mt Ser RNase H GGCAAAAAAGGAAGGAATCGAACCCCCCAAAG
    mt Trp RNase H GGCAGAAATTAAGTATTGCAACTTACTG
    mt Phe RNase H GGTGTTTATGGGGTGATGTGAGCCCGTCTA
    mt Leu RNase H GGTGTTAAGAAGAGGAATTGAACCTCTGACTG
    mt Tyr RNase H GGTGGTAAAAAGAGGCCTAACCCCTGTCT
    mt Cys RNase H GGAAGCCCCGGCAGGTTTGAAGCTGCTCT
    cyto-Leu CAA RNase H CCCCTCTGAGGCTTGAACTCAGGACCATTC
    cyto-Leu UAA-1 RNase H AGAAGAGGAGTTGAACCTCTGATTATAAA
    cyto-Leu UAA-2 RNase H TGATTATAAAGTTTTAAGTCTTATGCAA
    cyto-Cys RNase H GGGGGCACCTGGATTTGAATCAGGGACCTC
    Sec-1 AAS/RNase H GCCCGAAAGGTGGAATTG
    Sec-2 AAS/RNase H CCTACAAAGGTGGAATTG
Subcloning
    TRIT1 clone NdeI forward primer AATCGATA CAT ATG GCG TCC GTG GCG GCT GC
    TRIT1 clone XhoI reverse primer TACGTACG CTC GAG TTA AAC GCT GCA TTT CAG C
In vitro modification oligonucleotides
    Ser AGA RNA rG rArUrG rGrArC rUrArG rArArA rUrCrC rArUrC
    Ser CGA RNA rG rUrUrG rGrArC rUrCrG rArArA rUrCrC rArA rC
    Ser UGA RNA rG rArUrG rGrArC rUrUrG rArArA rUrCrC rArUrC
    Leu CAA RNA rG rUrCrArG rUrCrU rCrArA rArArU rCrUrGrA rC
    Leu UAA-1 RNA rG rUrArArArA rCrUrU rArArArA rUrUrUrUrArC
    Leu UAA-2 RNA rG rUArA rGrArC rUrUrA rArArA rCrUrU rUrArC
    Cys GCA RNA rG rUrUrU rGrArC rUrGrC rArArA rUrCrA rArGrC
    Sec UCA RNA rG rUrGrC rArGrG rCrUrU rCrArA rArCrC rUrGrU rArC
HHS Vulnerability Disclosure